Article Menu
Need Help?
No Article Versions Notes Found
Cite
Nogueira-Costa, G.; Fernandes, I.; Gameiro, R.; Gramaça, J.; Xavier, A.T.; Pina, I. Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities. Curr. Oncol. 2020, 27, 237-243. https://doi.org/10.3747/co.27.6573
Nogueira-Costa G, Fernandes I, Gameiro R, Gramaça J, Xavier AT, Pina I. Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities. Current Oncology. 2020; 27(5):237-243. https://doi.org/10.3747/co.27.6573
Chicago/Turabian StyleNogueira-Costa, G., I. Fernandes, R. Gameiro, J. Gramaça, A.T. Xavier, and I. Pina. 2020. "Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities" Current Oncology 27, no. 5: 237-243. https://doi.org/10.3747/co.27.6573
APA StyleNogueira-Costa, G., Fernandes, I., Gameiro, R., Gramaça, J., Xavier, A. T., & Pina, I. (2020). Prognostic Utility of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Colorectal Cancer Treated Using Different Modalities. Current Oncology, 27(5), 237-243. https://doi.org/10.3747/co.27.6573
